Evidence supports potential value for tumor grading, biopsy targeting, molecular characterization, assessment of infiltrative tumor, and differentiation of tumor progression from treatment-related change, but wider clinical translation will require harmonized acquisition and processing, cross-vendor validation, and pro...
S. Turk, John Kim, A. Rajan et al.· Academic Radiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.